Related Experiment Video
Updated: Apr 15, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Invasive Pulmonary Aspergillosis Presenting as a Giant Abscess in a Post-tuberculosis Destroyed Lung: A Case Report
Joke Goethals1,2, Robina Aerts1,2, Abraham Van Poppel1
1Department of Pulmonology, University Hospital of Antwerp, Antwerp, BEL.
Abstract:
Invasive pulmonary aspergillosis (IPA) is a severe fungal infection caused by Aspergillus mold, primarily affecting immunocompromised individuals, but increasingly seen in those with critical illness (e.g., viral infections) or in a subacute form in those with severe lung disease. We report the case of a 38-year-old woman with a history of pulmonary tuberculosis (TB) and a suspicion of post-TB chronic pulmonary aspergillosis who presented with dyspnoea and a productive cough unresponsive to antibiotics. Her condition rapidly evolved to respiratory insufficiency requiring intubation. Imaging revealed an extensive abscess in the left upper lobe with surrounding consolidation. Bronchoscopy showed a large amount of mucus requiring clearance. Cytopathology and cultures confirmed Aspergillus fumigatus (A. fumigatus). Laboratory testing showed marked eosinophilia, elevated total immunoglobulin-E, and positive A. fumigatus precipitins. The combination of a predisposing factor (post-tuberculosis cavities), cultures, and radiological findings was compatible with the diagnosis of subacute invasive pulmonary aspergillosis or chronic cavitating aspergillosis, as strictu sensu diagnosis of probable invasive aspergillosis could not be made (as typical immunocompromising host factors were not met). However, the disease was rapidly progressive, and the patient exhibited a good clinical, biochemical, and radiological evolution under voriconazole therapy. Long-term antifungal therapy will be required. This case highlights the importance of considering IPA, even in patients without classic profound immunosuppression, and recognizing post-tuberculosis cavities as a significant predisposing factor.
Insights
Invasive pulmonary aspergillosis (IPA) can affect individuals without profound immunosuppression, particularly those with prior tuberculosis. Early diagnosis and voriconazole treatment are crucial for managing this severe fungal infection.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Invasive pulmonary aspergillosis (IPA) is a severe fungal infection.
- It typically affects immunocompromised individuals but is increasingly seen in critical illness or severe lung disease.
- Post-tuberculosis lung cavities are a potential predisposing factor.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders

